255 related articles for article (PubMed ID: 7647216)
1. Tissue factor interactions with factor VII: measurement and clinical significance of factor VIIa in plasma.
Morrissey JH
Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S14-9. PubMed ID: 7647216
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor modulation of factor VIIa activity: use in measuring trace levels of factor VIIa in plasma.
Morrissey JH
Thromb Haemost; 1995 Jul; 74(1):185-8. PubMed ID: 8578455
[No Abstract] [Full Text] [Related]
3. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
[TBL] [Abstract][Full Text] [Related]
4. Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study.
Miller GJ; Stirling Y; Esnouf MP; Heinrich J; van de Loo J; Kienast J; Wu KK; Morrissey JH; Meade TW; Martin JC
Thromb Haemost; 1994 Jan; 71(1):38-48. PubMed ID: 8165645
[TBL] [Abstract][Full Text] [Related]
5. Factor VII assays.
Hayes TE; Pike J; Tracy RP
Arch Pathol Lab Med; 1993 Jan; 117(1):52-7. PubMed ID: 8418763
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation.
Morrissey JH; Macik BG; Neuenschwander PF; Comp PC
Blood; 1993 Feb; 81(3):734-44. PubMed ID: 8427965
[TBL] [Abstract][Full Text] [Related]
7. Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa.
Dickinson CD; Shobe J; Ruf W
J Mol Biol; 1998 Apr; 277(4):959-71. PubMed ID: 9545384
[TBL] [Abstract][Full Text] [Related]
8. Factor VIIa's first epidermal growth factor-like domain's role in catalytic activity.
Jin J; Chang J; Chang JY; Kelley RF; Stafford DW; Straight DL
Biochemistry; 1999 Jan; 38(4):1185-92. PubMed ID: 9930978
[TBL] [Abstract][Full Text] [Related]
9. Coagulation factor VII in middle-aged women with and without coronary heart disease.
Eriksson-Berg M; Silveira A; Orth-Gomér K; Hamsten A; Schenck-Gustafsson K
Thromb Haemost; 2001 May; 85(5):787-92. PubMed ID: 11372669
[TBL] [Abstract][Full Text] [Related]
10. Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C.
Safa O; Morrissey JH; Esmon CT; Esmon NL
Biochemistry; 1999 Feb; 38(6):1829-37. PubMed ID: 10026263
[TBL] [Abstract][Full Text] [Related]
11. Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin.
Lormeau JC; Herault JP; Herbert JM
Thromb Haemost; 1996 Jul; 76(1):5-8. PubMed ID: 8819242
[TBL] [Abstract][Full Text] [Related]
12. Functional consequences of mutations in Ser-52 and Ser-60 in human blood coagulation factor VII.
Iino M; Foster DC; Kisiel W
Arch Biochem Biophys; 1998 Apr; 352(2):182-92. PubMed ID: 9587405
[TBL] [Abstract][Full Text] [Related]
13. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
[TBL] [Abstract][Full Text] [Related]
14. Factor VII and haemostasis.
Osterud B
Blood Coagul Fibrinolysis; 1990 Jun; 1(2):175-81. PubMed ID: 2130929
[TBL] [Abstract][Full Text] [Related]
15. Seminal factor VII and factor VIIa: supporting evidence for the presence of an active tissue factor-dependent coagulation pathway in human semen.
Lwaleed BA; Goyal A; Delves G; Gossai S; Greenfield RS; Cooper AJ
Int J Androl; 2007 Dec; 30(6):543-9. PubMed ID: 17459125
[TBL] [Abstract][Full Text] [Related]
16. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor-dependent autoactivation of human blood coagulation factor VII.
Yamamoto M; Nakagaki T; Kisiel W
J Biol Chem; 1992 Sep; 267(27):19089-94. PubMed ID: 1527033
[TBL] [Abstract][Full Text] [Related]
19. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
Jin J; Perera L; Stafford D; Pedersen L
J Mol Biol; 2001 Apr; 307(5):1503-17. PubMed ID: 11292356
[TBL] [Abstract][Full Text] [Related]
20. A comparison of methods for the measurement of activated factor VII.
Kitchen S; Malia RG; Preston FE
Thromb Haemost; 1992 Sep; 68(3):301-5. PubMed ID: 1440496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
